Peter S. Zammit

London, ENG SE11UL, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.

Advanced iPSC-based modelling of LMNA-related congenital muscular dystrophy enables development of genetic therapies for muscle laminopathies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 16, 2025

Biallelic PAX7 variants cause a novel Satellite Cell-opathy with progressive muscle involvement resembling facioscapulohumeral muscular dystrophy.

Biallelic PAX7 variants cause a novel Satellite Cell-opathy with progressive muscle involvement resembling facioscapulohumeral muscular dystrophy.

Journal: Cell death & disease

Published: September 30, 2025

DUX4 at 25: how it emerged from "junk DNA" to become the cause of facioscapulohumeral muscular dystrophy.

DUX4 at 25: how it emerged from "junk DNA" to become the cause of facioscapulohumeral muscular dystrophy.

Journal: Skeletal muscle

Published: April 14, 2025

Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease.

Prenatal and progressive coenzyme Q10 administration to mitigate muscle dysfunction in mitochondrial disease.

Journal: Journal of cachexia, sarcopenia and muscle

Published: March 15, 2024

The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected.

The DUX4-HIF1α Axis in Murine and Human Muscle Cells: A Link More Complex Than Expected.

Journal: International journal of molecular sciences

Published: December 29, 2023

Transcriptomic gene signatures measure satellite cell activity in muscular dystrophies.

Transcriptomic gene signatures measure satellite cell activity in muscular dystrophies.

Journal: iScience

Published: December 12, 2023

Yap/Taz activity is associated with increased expression of phosphoglycerate dehydrogenase that supports myoblast proliferation.

Yap/Taz activity is associated with increased expression of phosphoglycerate dehydrogenase that supports myoblast proliferation.

Journal: Cell and tissue research

Published: May 17, 2023

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy.

An in silico FSHD muscle fiber for modeling DUX4 dynamics and predicting the impact of therapy.

Journal: eLife

Published: April 13, 2023

FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation.

FSHD muscle shows perturbation in fibroadipogenic progenitor cells, mitochondrial function and alternative splicing independently of inflammation.

Journal: Human molecular genetics

Published: April 13, 2023

Isolation, Culture, and Analysis of Zebrafish Myofibers and Associated Muscle Stem Cells to Explore Adult Skeletal Myogenesis.

Isolation, Culture, and Analysis of Zebrafish Myofibers and Associated Muscle Stem Cells to Explore Adult Skeletal Myogenesis.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: March 30, 2023

Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.

Hypoxia enhances human myoblast differentiation: involvement of HIF1α and impact of DUX4, the FSHD causal gene.

Journal: Skeletal muscle

Published: December 19, 2022

The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy.

The FSHD muscle-blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy.

Journal: Brain communications

Published: December 16, 2022

Showing 1-12 of 76

Last Updated: 09/26/2026